Nanyang Biologics
News,Biotech / MedTech,Singapore
Nanyang Biologics announces $1.5B business combination with RF Acquisition Corp II to pursue Nasdaq listing
Nanyang Biologics Pte. Ltd. (NYB), together with its subsidiaries, announced the signing of a business combination agreement with RF Acquisition Corp II, a publicly listed special purpose acquisition company, to pursue Nasdaq listing.
October 6, 2025
Nanyang Biologics, Equinix and HPE team up for AI drug discovery platform
Singapore artificial intelligence (AI) biotech firm Nanyang Biologics Pte Ltd (NYB) is teaming up with Equinix and HPE to offer Vecura, an as-a-Service proprietary AI-driven platform for drug discovery to advance development from natural sources.
August 29, 2025
DEEPX commits over $100M to Samsung-made AI chip
November 17, 2026
Samsung sets December 10 launch for Gemini-powered AI glasses
November 17, 2026
DEEPX commits over $100M to Samsung-made AI chip
November 17, 2026
Samsung sets December 10 launch for Gemini-powered AI glasses
November 17, 2026





